Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels
Serum thymidine kinase (TK), zeta-associated protein of 70 kDa (ZAP-70) and CD38 levels have been shown to be correlated with survival in chronic lymphocytic leukaemia (CLL). Aim: To investigate the possible correlations between TK, ZAP-70 and CD38 levels as prognostic markers in new diagnosed Rai s...
Збережено в:
Дата: | 2011 |
---|---|
Автори: | , , , |
Формат: | Стаття |
Мова: | English |
Опубліковано: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2011
|
Назва видання: | Experimental Oncology |
Теми: | |
Онлайн доступ: | http://dspace.nbuv.gov.ua/handle/123456789/138626 |
Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
Цитувати: | Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels / A. Rivkina, G. Vitols, M. Murovska, S. Lejniece // Experimental Oncology. — 2011. — Т. 33, № 2. — С. 99-103. — Бібліогр.: 30 назв. — англ. |
Репозитарії
Digital Library of Periodicals of National Academy of Sciences of Ukraineid |
irk-123456789-138626 |
---|---|
record_format |
dspace |
spelling |
irk-123456789-1386262018-06-20T03:08:22Z Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels Rivkina, A. Vitols, G. Murovska, M. Lejniece, S. Original contributions Serum thymidine kinase (TK), zeta-associated protein of 70 kDa (ZAP-70) and CD38 levels have been shown to be correlated with survival in chronic lymphocytic leukaemia (CLL). Aim: To investigate the possible correlations between TK, ZAP-70 and CD38 levels as prognostic markers in new diagnosed Rai stages of CLL patients. Methods: 120 CLL patients were enrolled. ELISA was used to measure serum TK level, flow cytomerty — to determine ZAP-70 and CD38 expression applying ZAP-70 Kit and monoclonal antibody to CD38, respectively. Results: Significantly higher levels of TK were found in the high progression group of CLL patients that corresponded to stage II (Rai classification). An elevated level of TK, CD38 and ZAP-70 together was also found in the II stage. The coefficient of correlation between CD38 and ZAP-70 is reliable (p < 0.001). There is also a correlation between the level of TK and the disease stage (p < 0.05). Other parameters do not show this correlation. Conclusion: The determination of TK, ZAP-70 and CD38 together allows patients susceptible to a possible stage of the disease, to be identified. Estimation of the factors at an early stage of the disease may allow an earlier commencement of treatment. 2011 Article Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels / A. Rivkina, G. Vitols, M. Murovska, S. Lejniece // Experimental Oncology. — 2011. — Т. 33, № 2. — С. 99-103. — Бібліогр.: 30 назв. — англ. 1812-9269 http://dspace.nbuv.gov.ua/handle/123456789/138626 en Experimental Oncology Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
institution |
Digital Library of Periodicals of National Academy of Sciences of Ukraine |
collection |
DSpace DC |
language |
English |
topic |
Original contributions Original contributions |
spellingShingle |
Original contributions Original contributions Rivkina, A. Vitols, G. Murovska, M. Lejniece, S. Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels Experimental Oncology |
description |
Serum thymidine kinase (TK), zeta-associated protein of 70 kDa (ZAP-70) and CD38 levels have been shown to be correlated with survival in chronic lymphocytic leukaemia (CLL). Aim: To investigate the possible correlations between TK, ZAP-70 and CD38 levels as prognostic markers in new diagnosed Rai stages of CLL patients. Methods: 120 CLL patients were enrolled. ELISA was used to measure serum TK level, flow cytomerty — to determine ZAP-70 and CD38 expression applying ZAP-70 Kit and monoclonal antibody to CD38, respectively. Results: Significantly higher levels of TK were found in the high progression group of CLL patients that corresponded to stage II (Rai classification). An elevated level of TK, CD38 and ZAP-70 together was also found in the II stage. The coefficient of correlation between CD38 and ZAP-70 is reliable (p < 0.001). There is also a correlation between the level of TK and the disease stage (p < 0.05). Other parameters do not show this correlation. Conclusion: The determination of TK, ZAP-70 and CD38 together allows patients susceptible to a possible stage of the disease, to be identified. Estimation of the factors at an early stage of the disease may allow an earlier commencement of treatment. |
format |
Article |
author |
Rivkina, A. Vitols, G. Murovska, M. Lejniece, S. |
author_facet |
Rivkina, A. Vitols, G. Murovska, M. Lejniece, S. |
author_sort |
Rivkina, A. |
title |
Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels |
title_short |
Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels |
title_full |
Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels |
title_fullStr |
Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels |
title_full_unstemmed |
Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels |
title_sort |
identifying the stage of new cll patients using tk, zap-70, cd38 levels |
publisher |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
publishDate |
2011 |
topic_facet |
Original contributions |
url |
http://dspace.nbuv.gov.ua/handle/123456789/138626 |
citation_txt |
Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels / A. Rivkina, G. Vitols, M. Murovska, S. Lejniece // Experimental Oncology. — 2011. — Т. 33, № 2. — С. 99-103. — Бібліогр.: 30 назв. — англ. |
series |
Experimental Oncology |
work_keys_str_mv |
AT rivkinaa identifyingthestageofnewcllpatientsusingtkzap70cd38levels AT vitolsg identifyingthestageofnewcllpatientsusingtkzap70cd38levels AT murovskam identifyingthestageofnewcllpatientsusingtkzap70cd38levels AT lejnieces identifyingthestageofnewcllpatientsusingtkzap70cd38levels |
first_indexed |
2023-10-18T21:18:29Z |
last_indexed |
2023-10-18T21:18:29Z |
_version_ |
1796152480027901952 |